VS-6063 inhibits FAK, which is responsible for driving the formation of fibrotic desmoplastic tumor stroma composed of α-smooth muscle actin (α-SMA)+ cancer-associated fibroblasts (CAFs) and dense collagen-rich extracellular matrix (ECM) 34-36. The gene discussed is ACTA1; the disease is neoplasm.